☆ 4.1 Article

Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal

JOURNAL OF MEDICAL ECONOMICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project

John Paget et al.

Summary: This study estimates the influenza-associated mortality in different age groups and countries of the European Union. The mortality rates are significantly higher among individuals aged 65 years and older compared to those younger than 65. The study also finds no negative correlation between vaccination coverage rates and influenza-associated mortality in the elderly.

VACCINE (2022)

添加到收藏夹

Article Infectious Diseases

Excess hospitalizations and mortality associated with seasonal influenza in Portugal, 2008-2018

Filipe Froes et al.

Summary: The study revealed an underestimation of influenza in the Portuguese population, with a high burden of severe influenza impacting both the elderly and younger age groups.

BMC INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season

Lisa A. Grohskopf et al.

MMWR Recommendations and Reports (2022)

添加到收藏夹

Article Immunology

The disease burden of influenza beyond respiratory illness

Alejandro E. Macias et al.

Summary: Influenza, primarily known as a respiratory infection, also has broader consequences such as cardiovascular events, exacerbations of chronic illnesses, increased susceptibility to secondary infections, functional decline, and poor pregnancy outcomes. Understanding these broader consequences is crucial for assessing the full burden of influenza and the value of preventive measures among different populations.

VACCINE (2021)

添加到收藏夹

Review Immunology

Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature review

Florian Colrat et al.

Summary: For adults aged >= 65 years, the high-dose trivalent inactivated influenza vaccine (IIV3-HD) is more effective and cost-saving compared to the standard-dose trivalent inactivated influenza vaccine (IIV3-SD), primarily by reducing hospitalizations for cardiorespiratory events.

VACCINE (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial

Stephanie Pepin et al.

Summary: In adults aged 60 and older, the quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) showed superior immunogenicity compared to the standard-dose quadrivalent influenza vaccine (IIV4-SD), particularly against all four influenza strains. Both vaccines were well-tolerated in this age group, with no safety concerns identified.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

添加到收藏夹

Article Immunology

Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine

Esther Redondo et al.

Summary: The study evaluated the cost-utility of switching to high-dose inactivated influenza quadrivalent vaccine (HD-QIV) strategy compared to adjuvanted trivalent inactivated vaccine (aTIV) strategy in the population above 65 years of age in Spain. The results showed that HD-QIV could reduce cases of influenza, GP visits, hospitalizations, deaths, while increasing life-years and quality-adjusted life-years. Healthcare costs increased, but the strategy was considered cost-effective.

VACCINE (2021)

添加到收藏夹

Article Economics

Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales

Richard Mattock et al.

Summary: The cost-effectiveness analysis showed that in the 65+ population in England and Wales, using HD TIV instead of aTIV has better clinical benefits and economic outcomes. HD TIV can reduce the number of influenza cases, deaths, hospitalizations, and GP appointments.

JOURNAL OF MEDICAL ECONOMICS (2021)

添加到收藏夹

Review Public, Environmental & Occupational Health

Variability in published rates of influenza-associated hospitalizations: A systematic review, 2007-2018

Katherine M. Roguski et al.

JOURNAL OF GLOBAL HEALTH (2020)

添加到收藏夹

Article Immunology

Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease

Robertus van Aalst et al.

VACCINE (2019)

添加到收藏夹

Article Immunology

Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults ≥65 years of age: A phase 3 randomized clinical trial

Lee-Jah Chang et al.

VACCINE (2019)

添加到收藏夹

Article Immunology

Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis

Jason K. H. Lee et al.

EXPERT REVIEW OF VACCINES (2018)

添加到收藏夹

Article Medicine, General & Internal

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

A. Danielle Iuliano et al.

LANCET (2018)

添加到收藏夹

Review Immunology

Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis

Mitchell P. Somes et al.

VACCINE (2018)

添加到收藏夹

Article Clinical Neurology

Influenza-like illness as a trigger for ischemic stroke

Amelia K. Boehme et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)

添加到收藏夹

Article Biotechnology & Applied Microbiology

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors

Debbie L. Becker et al.

Human Vaccines & Immunotherapeutics (2016)

添加到收藏夹

Article Medicine, General & Internal

Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study

Marc Baguelin et al.

BMC MEDICINE (2015)

添加到收藏夹

Article Immunology

Impact of influenza vaccination on mortality in the French elderly population during the 2000-2009 period

Isabelle Bonmarin et al.

VACCINE (2015)

添加到收藏夹

Article Immunology

Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines

Carlos A. DiazGranados et al.

VACCINE (2015)

添加到收藏夹

Article Immunology

Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors

Ayman Chit et al.

VACCINE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

The role of influenza in the epidemiology of pneumonia

Sourya Shrestha et al.

Scientific Reports (2015)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

Carlos A. DiazGranados et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Health Care Sciences & Services

The valuation of the EQ-5D in Portugal

Lara N. Ferreira et al.

QUALITY OF LIFE RESEARCH (2014)

添加到收藏夹

Article Public, Environmental & Occupational Health

Estimating influenza vaccine effectiveness using routinely collected laboratory data

D. M. Fleming et al.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2010)

添加到收藏夹

Article Immunology

Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older

Ann R. Falsey et al.

JOURNAL OF INFECTIOUS DISEASES (2009)

添加到收藏夹

Review Public, Environmental & Occupational Health

Time lines of infection and disease in human influenza: A review of volunteer challenge studies

Fabrice Carrat et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)

添加到收藏夹

Review Medicine, General & Internal

Complications of viral influenza

Michael B. Rothberg et al.

AMERICAN JOURNAL OF MEDICINE (2008)

添加到收藏夹

Article Health Care Sciences & Services

Swedish population health-related quality of life results using the EQ-5D

K Burstrom et al.

QUALITY OF LIFE RESEARCH (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.